Viewing nowCombinationBildamet Tablet 50/1000 mg
Vildagliptin Nitrate 60.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 202107715 · Approved 2021.11.30 · Insurance code 665003150
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood sugar control in patients with type 2 diabetes by using vildagliptin and metformin together. It is typically administered as an adjunct to diet and exercise to effectively reduce blood sugar levels and is expected to have positive effects on diabetes management.
For the treatment of patients with type 2 diabetes, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding vildagliptin 100mg and metformin 2000mg. Doses of vildagliptin greater than 100mg per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous antidiabetic drug treatment whose blood glucose is inadequately controlled with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily; the dose may be gradually increased to 1 tablet of 50/1000mg twice daily. 2. Patients whose blood glucose is not adequately controlled with metformin monotherapy: The initial dose is vildagliptin 100mg per day plus the patient's current metformin dose. The initial dose of this medicine is determined according to the patient's current treatment regimen; take 1 tablet of this medicine 50mg/850mg or 50mg/1000mg twice daily, in the morning and evening. 3. Patients switching from concomitant vildagliptin and metformin therapy: Patients switching from concomitant vildagliptin and metformin therapy to this medicine may start at their previous doses of vildagliptin and metformin. 4. Use in combination with a sulfonylurea or insulin: Administer vildagliptin 50mg twice daily (total daily dose 100mg) and metformin at a dose similar to the patient's existing dose. When this medicine is used in combination with a sulfonylurea, the sulfonylurea dose may need to be reduced to decrease the risk of hypoglycemia. No studies have evaluated the safety and efficacy of switching from another oral hypoglycemic agent to this medicine. Any change in type 2 diabetes treatment may alter blood glucose control; use caution and ensure appropriate monitoring. If a dose of this medicine is missed, take it with the next meal unless it is time to take the missed dose; do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST level before treatment exceeds 2.5 times the upper limit of normal.
This medication may cause severe lactic acidosis or hypoglycemia, so it should not be administered to patients with moderate to severe renal impairment or heart failure. Patients receiving this medication should stop taking it at least 48 hours before tests using radiopaque iodine contrast agents that can induce acute renal failure, and should resume taking it after confirming normal kidney function. Pregnant or nursing women, and individuals who have hypersensitivity to this medication or its ingredients should not use this medication. Patients with irregular meal patterns or insufficient food intake, those undergoing intense exercise, or those using other medications should use caution as there is a risk of hypoglycemia and lactic acidosis. Regular monitoring of liver and kidney function should be conducted during treatment, and treatment should be avoided in patients with liver dysfunction. If symptoms of dehydration, severe diarrhea, or vomiting occur, this medication should be discontinued immediately and a doctor consulted. Due to the risk of acute pancreatitis, if symptoms like abdominal pain, nausea, or vomiting occur while taking this medication, medical personnel should be notified immediately. This medication can cause hypoglycemia, particularly in elderly, frail, or malnourished patients, who should be closely monitored for symptoms of hypoglycemia. Alcohol consumption may increase the risk of lactic acidosis; therefore, excessive drinking should be avoided while taking this medication. Patients scheduled for surgery should discontinue this medication 48 hours before the procedure and can resume once oral intake is possible and kidney function is confirmed to be normal. This medication is not recommended for children or adolescents under 18 years of age as its safety and efficacy in this population has not been established. Elderly patients may have reduced kidney function, so appropriate dosage adjustments should be made based on frequent kidney function testing. In case of overdose, medical personnel should be notified immediately, and treatment such as hemodialysis may be necessary. If any skin blisters or ulcers develop during treatment, a doctor should be consulted immediately; discontinuation of the medication should also be considered if severe joint pain occurs. During treatment, regular monitoring of blood glucose and HbA1c levels should be performed to ensure proper blood glucose control.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be kept in a cool place at a temperature below 30 degrees Celsius to maintain its effectiveness.
Dark yellow oval film-coated tablet
30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationVildagliptin Nitrate 60.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationVildagliptin Nitrate 60.4mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationVildagliptin Nitrate 60.4mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.